This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1976-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Rahway, NJ (US) (1976)
- Clark, NJ (US) (1990)
Company Filing History:
Years Active: 1976-1990
Title: Arthur J Zambito: Innovator in Pharmaceutical Chemistry
Introduction
Arthur J Zambito is a notable inventor based in Clark, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. His work focuses on the development of innovative processes and compositions that enhance the efficacy of pharmaceutical compounds.
Latest Patents
Zambito's latest patents include the development of crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine and crystalline salts of (R,S)-pivaloyloxyethyl esters of (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine. These patents disclose processes for their preparation and pharmaceutical compositions. Additionally, he has patented a process for extracting and purifying 3,6-bis(5-chloro-2-piperidinyl)-2,5-piperazinedione dihydrochloride, also known as Compound 593A. This process involves the purification of the compound obtained from the fermentation broth of a strain of Streptomyces griseoluteus, utilizing a resin for adsorption and subsequent purification through fractional crystallization.
Career Highlights
Arthur J Zambito is currently associated with Merck & Co., Inc., where he continues to innovate in the pharmaceutical sector. His expertise in chemical processes and formulations has contributed to advancements in drug development.
Collaborations
Throughout his career, Zambito has collaborated with esteemed colleagues such as John Budavari and Robert F Czaja. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Arthur J Zambito stands out as a significant figure in pharmaceutical innovation, with a focus on improving drug formulations and processes. His contributions through patents and collaborations reflect his commitment to advancing the field of pharmaceutical chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
